Nabumetone
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names: Nabumetonum, Nabumetona, Arthaxan, Balmox, Consolan, Dolsinal, Flambate, Listran, Mebutan, Nabuser, Prodac, Relafen, Relif, Relifen, Relifex, Unimetone
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Dosing and Administration
The recommended starting dose is 1,000 mg taken as a
single dose with or without food. Some patients may obtain more symptomatic relief from 1,500 mg to
2,000 mg per day. RELAFEN can be given in either a single or twice-daily dose. Dosages greater than
2,000 mg per day have not been studied. The lowest effective dose should be used for chronic
treatment. Caution should be used in prescribing RELAFEN to patients with
moderate or severe renal insufficiency. The maximum starting doses of RELAFEN in patients with
moderate or severe renal insufficiency should not exceed 750 mg or 500 mg, respectively once daily.
Following careful monitoring of renal function in patients with moderate or severe renal insufficiency,
daily doses may be increased to a maximum of 1,500 mg and 1,000 mg, respectively
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Nabumetone
Return to top
Publication Resources
Most Recent Articles on Nabumetone
Review Articles on Nabumetone
Articles on Nabumetone in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Nabumetone
Return to top
Trial Resources
Ongoing Trials with Nabumetone at Clinical Trials.gov
Trial Results with Nabumetone
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Nabumetone
Cochrane Collaboration on Nabumetone
Cost Effectiveness of Nabumetone
Return to top
Media Resources
Powerpoint Slides on Nabumetone
Images of Nabumetone
Podcasts & MP3s on Nabumetone
Videos on Nabumetone
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Nabumetone
Discussion Groups on Nabumetone
Patient Handouts on Nabumetone
Blogs on Nabumetone
Nabumetone in the News
Nabumetone in the Marketplace
Return to top
Nabumetone Dosage and Drug Interaction
International Resources
Nabumetone en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
